Aequus Pharmaceuticals Inc V.AQS

Alternate Symbol(s): AQSZF

Healthcare

Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company focused on developing, advancing, and promoting differentiated products. The Company is engaged in the sale and marketing of several commercial products in ophthalmology and transplant. Its pipeline products include Evolve Intensive Gel, Evolve Daily Intensive, SCOPE Portfolio, Zimed PF and REV-0100 / ReVision. Evolve Intensive Gel and Evolve Daily Intensive contains lubricating eye drops intended for use in the relief of discomfort that arises from dry eye sensations, including dryness, soreness, feelings of grit, and irritation. Zimed PF is a preservative-free multi-dose Bimatoprost for glaucoma patients in Canada. REV-0100 is in preclinical development as a treatment for Stargardt disease. It plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license.

TSXV:AQS - Post by User

Aequus Pharmaceuticals Inc

Bullboard Posts

Comment by 300Magnumon Mar 20, 2015 3:13pm

99 Views

Post# 23544607

RE:RE:RE:RE:Managment

MPG, Couldnt decide but dropped out at .85, next day........90. Oh well, alot better than the .70 it sits at right now.

I will wait on this for awhile and take some time doing some DD.

Looks good at a glance. Dont know if it s a fit for me at this time. I dont like the long long positions.

Bullboard Posts

Quest Diagnostics to acquire LifeLabs from OMERS for C$1.35 billion